Considering the persistently high inflation, the Fed will likely announce another aggressive interest rate hike this week. Amid growing recession concerns, investing in quality dividend-paying stocks Walmart (WMT), Pfizer (PFE),…

Read more...

Gold is facing headwinds from a strong U.S. dollar and the expectations of aggressive interest rate hikes. Therefore, we believe gold stocks Buenaventura Mining (BVN), Hycroft Mining (HYMC), and GoldMining…

Read more...

The return of the meme stock frenzy has led several fundamentally weak stocks to soar to unsustainable prices. With the stock market expected to remain under pressure in the upcoming…

Read more...

It will likely take new lows in QQQ for new highs in VXN- and for a new buy signal to emerge.

Read more...

Last week, I talked about the likelihood of the S&P 500 (SPY) remaining range-bound due to the mix of bullish and bearish forces. One of the bullish forces was the…

Read more...

The 20% loss for the S&P 500 (SPY) this year does not really tell the story of the pain inflicted on the average investor. Most individuals were piled up in…

Read more...

It is now clear the summer bear market rally is over. Now we are descending back into bear market territory with a retest of the S&P 500 (SPY) lows at…

Read more...

Biotech company bluebird bio (BLUE) received FDA approval for ZYNTEGLO last month, which seems to have boosted its stock price. However, given its bleak profitability and stretched valuations, the stock…

Read more...

Biopharmaceutical giant Gilead Sciences (GILD) has delivered solid segmental sales growth in the last reported quarter. In addition, the company’s various research breakthroughs and drug approvals should further bolster its…

Read more...

Chip company Micron Technology (MU) is gearing up to make its $15 billion chip factory operational. The company seems poised to recreate an Nvidia (NVDA)-like success story in the coming…

Read more...